🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Michael C. Burns

ORCID: 0000-0002-2686-059X
Biochemistry, Genetics and Molecular BiologyMedicineMaterials Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Molecular profiling of early-stage colorectal cancer (CRC) using targeted next generation sequencing (NGS) to predict signatures of recurrence.”.

Molecular profiling of early-stage colorectal cancer (CRC) using targeted next generation sequencing (NGS) to predict signatures of recurrence.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.242
N/A
0DataRank · unranked
2 citations

Kristen Carroll, Ryan Jones, Masha Kocherginsky, Kirsten B. Burdett, Guang‐Yu Yang +3 more

Clinical utility of targeted next generation sequencing (NGS) to predict response to neoadjuvant therapy (NT) in rectal cancer (RC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.237
N/A
0DataRank · unranked
1 citations

Michael C. Burns, Ryan Jones, Masha Kocherginsky, Kirsten B. Burdett, Guang‐Yu Yang +3 more

A phase II study of sEphB4-HSA in metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.tps274
N/A
0DataRank · unranked
1 citations

Vinay Sagar, Borko Jovanovic, Alicia K. Morgans, David James VanderWeele, David I. Quinn +4 more

918O Telisotuzumab adizutecan (ABBV-400; Temab-A) in patients with MET-amplified (MET-amp) advanced solid tumors: Results from a phase I study

Annals of Oncology(2025)10.1016/j.annonc.2025.08.1487
N/A
0DataRank · unranked
2 citations

Yasutoshi Kuboki, John H. Strickler, Kanwal Pratap Singh Raghav, Antoine Hollebecque, D.H. Lee +15 more